Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -37.31% vs 5.25% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -6.64% vs 10.44% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is -29.69% vs -19.51% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is -3.21% vs -34.30% in Mar 2024
Compare Balance Sheet Results of Link Pharma Chem
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
4.44
4.91
-0.47
-9.57%
Share Warrants & Outstandings
Total Reserve
8.22
-4.37
12.59
288.10%
Shareholder's Funds
12.66
0.55
12.11
2,201.82%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.42
0.00
0.42
0.00%
Secured Loans
0.42
0.00
0.42
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-0.23
0.00
-0.23
0.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.16
0.00
0.16
0.00%
Total Non-Current Liabilities
0.35
0.00
0.35
0.00%
Current Liabilities
Trade Payables
3.48
0.05
3.43
6,860.00%
Other Current Liabilities
0.74
0.00
0.74
0.00%
Short Term Borrowings
5.37
0.71
4.66
656.34%
Short Term Provisions
0.46
0.00
0.46
0.00%
Total Current Liabilities
10.05
0.76
9.29
1,222.37%
Total Liabilities
23.06
1.31
21.75
1,660.31%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
15.95
0.00
15.95
0.00%
Less: Accumulated Depreciation
6.67
0.00
6.67
0.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
9.28
0.00
9.28
0.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
2.06
0.00
2.06
0.00%
Long Term Loans & Advances
0.53
0.00
0.53
0.00%
Other Non Current Assets
0.04
0.00
0.04
0.00%
Total Non-Current Assets
11.90
0.00
11.90
0.00%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
5.74
0.00
5.74
0.00%
Sundry Debtors
5.02
0.00
5.02
0.00%
Cash and Bank
0.06
0.02
0.04
200.00%
Other Current Assets
0.06
0.00
0.06
0.00%
Short Term Loans and Advances
0.28
1.29
-1.01
-78.29%
Total Current Assets
11.16
1.31
9.85
751.91%
Net Current Assets (Including Current Investments)
1.11
0.55
0.56
101.82%
Total Current Assets Excluding Current Investments
11.16
1.31
9.85
751.91%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
23.06
1.31
21.75
1,660.31%
Contingent Liabilities
0.11
0.01
0.10
1,000.00%
Total Debt
5.78
0.71
5.07
714.08%
Book Value per share (adjusted)
28.51
1.12
27.39
2,445.54%
Annual - Borrowings
Borrowings 5.78 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -37.31% vs 5.25% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 9.28 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -6.64% vs 10.44% in Mar 2024
Annual - Investments
Investments 2.06 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -29.69% vs -19.51% in Mar 2024
Annual - Current Assets
Current Assets 11.16 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -3.21% vs -34.30% in Mar 2024






